EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSPNYG00000002115
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSPNYG00000001305
Gene Symbol: RPSA
4 Cross references
515 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPNYG00000004672
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSPNYG00000013249
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Selectin E

Ensembl ID : ENSPNYG00000022544
Gene Symbol: SELE
4 Cross references
168 Possible Orthologues:

Selectin E

Ensembl ID : ENSPNYG00000022564
Gene Symbol: SELE
1 Cross references
167 Possible Orthologues:

Selectin E

Ensembl ID : ENSPNYG00000022573
Gene Symbol: SELE
1 Cross references
167 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSPNYG00000019508
Gene Symbol: LOC102200140
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Chk2-Like

Ensembl ID : ENSPNYG00000014172
Gene Symbol: LOC102215705
3 Cross references
205 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSPNYG00000005287
Gene Symbol: LOC102192917
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSPNYG00000004943
Gene Symbol: SERPINC1
3 Cross references
198 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSPNYG00000017374
Gene Symbol: LOC102211124
2 Cross references
347 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).